RDHL


RedHill Biopharma Ltd – ADR (RDHL) Shares Pop on Positive Clinical Outcome in Acute Gastroenteritis

RedHill Biopharma Ltd – ADR (NASDAQ:RDHL) released positive top-line results from the Phase III GUARD …

Roth Capital Maintains Buy On RedHill Following 2015 Outlook

In a research report released today, Roth Capital analyst Scott Henry reiterated a Buy rating …

Roth Capital Highlights RedHill As A Company To Watch In 2015; Raises PT To $27.50

In a research report issued today, Roth Capital analyst Scott Henry reiterated a Buy rating …

We Are Looking For An Eventful 2015 For RedHill Biopharma, Says MLV

MLV analyst Vernon Bernardino is out with a research report on RedHill Biopharma (NASDAQ:RDHL), reiterating a Buy rating …

MLV Cuts RedHill Price Target To Reflect A Delay In Rizaport Approval

In a research report issued today, MLV analyst Vernon Bernardino reiterated a Buy rating on …

Roth Capital Maintains Buy On RedHill, Boosts Price Target To $24

In a research note issued this morning, Roth Capital analyst Scott Henry maintained a Buy rating …